🇺🇸 FDA
Patent

US 11858943

Vasopressin receptor antagonists and products and methods related thereto

granted A61PA61P15/08A61P15/10

Quick answer

US patent 11858943 (Vasopressin receptor antagonists and products and methods related thereto) held by Neumora Therapeutics, Inc. expires Mon Dec 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Neumora Therapeutics, Inc.
Grant date
Tue Jan 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61P, A61P15/08, A61P15/10, A61P25/18, A61P25/20